Alan Bloom – PESI – Psychopharmacology for Mental Health Professionals download, Alan Bloom – PESI – Psychopharmacology for Mental Health Professionals review, Alan Bloom – PESI – Psychopharmacology for Mental Health Professionals free
Alan Bloom – PESI – Psychopharmacology for Mental Health Professionals
Most clients with DSM-5® diagnoses are being treated with a combination of psychological and pharmacological treatments. Newer drugs are being developed to treat mental disorders based on a better understanding of neurobiological contributions to mental disorders and the latest pharmacological research. To provide appropriate services, you are expected to have a thorough understanding of these common and complex issues. As a mental health professional, keeping up-to-date is essential.
This recording will update and increase your knowledge of:
Neurobiological underpinnings of major DSM-5® diagnoses
Effects and side effects of drugs used to treat these diagnoses
Responsibilities of the non-prescribing therapist to clients taking psychiatric medication
Specifics of the pharmacological treatment and drugs of choice for Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will be presented. Unique to this recording is information on the common types of psychotherapeutic drugs and other drugs that are abused, and methods for prevention and early detection. Throughout the day, representative case studies will generate discussion and examination of the latest drug treatment for DSM-5® disorders.
You will leave this recording with knowledge and confidence regarding effective and safe application of pharmacological drugs.
Speaker Alan S. Bloom, PhD, is professor of pharmacology and toxicology at the Medical College of Wisconsin where he teaches psychopharmacology to medical students and neuroscience graduate students. He earned a joint PhD in psychology and pharmacology and consults regularly with psychiatrists and attorneys in drug abuse and other pharmacology related cases.
Dr. Bloom has conducted extensive research on the impact of drugs of abuse (marijuana, cocaine, etc.) on the brain through use of functional magnetic resonance imaging (fMRI). He also directed research on the cognitive effects of chemotherapy drugs administered to women with breast cancer, commonly known as “chemo-brain”. His studies have been funded by the NIH and other national organizations and reported in an extensive number of publications and presentations. Dr. Bloom has served on the NIDA Center grant review panel and is an appointed member of the Controlled Substance Board of the State of Wisconsin.
Dr. Bloom is a strong and experienced presenter providing lively, information-packed seminars. He encourages the active learning of participants through application of the material in case studies and problem-based learning. In 1997 he was elected to membership in the Medical College of Wisconsin Society of Teaching Scholars.
Speaker Disclosures:
Financial: Dr. Alan Bloom has an employment relationship with the Medical College of Wisconsin. He receives a speaking honorarium and recording royalties from PESI, Inc. Dr. Alan has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Alan Bloom is the Vice Chair of the State of Wisconsin Controlled Substances Board. He is a member of the Organization for Human Brain Mapping, the International Brain Research Organization, and the International Society for Magnetic Resonance in Medicine.
Target Audience
Counselors
Psychotherapists
Psychologists
Social Workers
Nurse Practitioners
Case Managers
Marriage & Family Therapists
Addiction Counselors
Nurses
Clinical Nurse Specialists
Pharmacists
School Psychologists
Occupational Therapists
Occupational Therapy Assistants
Other Mental Health Professionals
Outline
PSYCHOPHARMACOLOGICAL FOUNDATIONS
Core Pharmacological Principles
Brain structures & circuits involved in:
Emotional regulation
Executive function & inhibitory control
Reward & pleasure
Learning & memory
Receptors and neurotransmitters important in the actions of psychopharmacological agents
Biogenic amines
Excitatory & inhibitory neurotransmitters
Endorphins & endocannabinoids
Your Role in Combined Psychological & Pharmacological Treatments
Collaboration & communication with prescribing professionals
Managing the combined treatments
Referrals for medication
Client psycho-education
Monitoring drug effects & side effects
Promoting adherence to combined treatments
DRUGS USED IN THE TREATMENT OF DSM-5® MENTAL DISORDERS Depressive Disorders
Neurobiology of depression
Drugs used to treat depressive disorders
Selective Serotonin Reuptake inhibitors (SSRIs)
– Effects, side effects and cautions
– Suicide risk & discontinuation syndrome
– Serotonin syndrome
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Effects, side effects, and cautions
Atypical antidepressant agents
Effects, side effects, and cautions
Tricyclic antidepressants (TCAs)
Effects, side effects, and cautions
Why were newer drugs needed?
MAO inhibitors
Effects, side effects, and cautions
Choosing an antidepressant
What if first-line antidepressants do not work?Augmentation with antipsychotics
Drugs used in the treatment of anxiety & insomnia
Benzodiazepines & Benzodiazepine-like drugs
Misuse of these drugs in treatment
SSRI’s & other drugs used to treat anxiety
ADHD
Psycho-stimulants
– Effects, side effects & cautions
Alpha-Adrenergic Agonists
Major neurocognitive disorders
Drugs used in the treatment of cognitive impairment
Future treatments
Prescription Drug Abuse
Mental disorders & risk of comorbid prescription drug abuse
Classes of drugs that are frequently abused
Stimulants
Sedative-hypnotics
Opiates
Strategies for the prevention & early identification of prescription drug abuse
LIMITATIONS OF RESEARCH AND POTENTIAL RISKS
Objectives
Communicate the neurotransmitter systems and neuroanatomy underlying the biological basis for mental disorders and pharmacotherapy.
Evaluate the role of mental health professionals who treat clients receiving both psychotherapeutic medications and psychotherapy.
Analyze the major classes of drugs used to treat mental disorders and which mental disorders are appropriately treated with each class of drugs.
Analyze the effects and side effects of various psychotropic medications, including antipsychotics, antidepressants, benzodiazepines and anticonvulsants.
Determine the abuse liability of drugs used in the treatment of anxiety, insomnia, pain and ADHD.
Implement methods for prevention and early identification of prescription drug abuse among clients.
Frequently Asked Questions:
Innovative Business Model:
Embrace the reality of a genuine business! Our approach involves forming a group buy, where we collectively share the costs among members. Using these funds, we purchase sought-after courses from sale pages and make them accessible to individuals facing financial constraints. Despite potential reservations from the authors, our customers appreciate the affordability and accessibility we provide.
The Legal Landscape: Yes and No:
The legality of our operations falls into a gray area. While we lack explicit approval from the course authors for resale, there’s a technicality at play. When procuring the course, the author didn’t specify any restrictions on resale. This legal nuance presents both an opportunity for us and a boon for those seeking budget-friendly access.
Quality Assurance: Unveiling the Real Deal:
Delving into the heart of the matter – quality. Acquiring the course directly from the sale page ensures that all documents and materials are identical to those obtained through conventional means. However, our differentiator lies in going beyond personal study; we take an extra step by reselling. It’s important to note that we are not the official course providers, meaning certain premium services aren’t included in our package:
No coaching calls or scheduled sessions with the author.
No access to the author’s private Facebook group or web portal.
No entry to the author’s exclusive membership forum.
No direct email support from the author or their team.
We operate independently, aiming to bridge the affordability gap without the additional services offered by official course channels. Your understanding of our unique approach is greatly appreciated.
Refund is acceptable:
Firstly, item is not as explained
Secondly, Item do not work the way it should.
Thirdly, and most importantly, support extension can not be used.
Thank you for choosing us! We’re so happy that you feel comfortable enough with us to forward your business here.
Reviews (0)
Reviews
There are no reviews yet.
Be the first to review “Alan Bloom – PESI – Psychopharmacology for Mental Health Professionals” Cancel reply
Reviews
There are no reviews yet.